Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
Pfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the
Read MorePfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the
Read MoreThe approval of a vaccine by Pfizer targeting RSV comes just weeks after the Food and Drug Administration cleared a
Read MoreThe FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus
Read MoreThe FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that
Read MoreThe FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential
Read More